Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptide Therapy Practitioners Clinical Protocol Guide: Protocol Comparison

Reconstitution Technique Direct injection onto powder, room-temp bacteriostatic water, no pressure equalisation Angled wall injection, pre-chilled bacteriostatic water (2–8°C), air volume equalisation pre-reconstitution High-compliance method reduces denaturat

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Reconstitution Technique
  • Direct injection onto powder, room-temp bacteriostatic water, no pressure equalisation
  • Angled wall injection, pre-chilled bacteriostatic water (2–8°C), air volume equalisation pre-reconstitution
  • High-compliance method reduces denaturation by 8–12% and prevents backflow contamination. Critical for multi-draw vials
  • Storage Temperature Control
  • Household refrigerator (unmonitored), estimated 2–8°C
  • Pharmaceutical-grade refrigerator with continuous data logging, alarm thresholds at 2°C/8°C
  • Temperature excursions >8°C for >30 min trigger measurable degradation. Unmonitored storage is the #1 avoidable protocol failure
  • Dosing Calculation Method
  • Direct µg/kg scaling from literature without overfill adjustment
  • Verify actual peptide mass via CoA, calculate concentration post-reconstitution accounting for 10–15% overfill
  • Overfill variance introduces 10–14% dosing error when ignored. CoA verification is mandatory for reproducible results
  • Draw Syringe Selection
  • Standard 1mL Luer-lock syringe (0.1mL graduations)
  • Insulin syringe with 0.01mL graduations for draws <0.3mL
  • Sub-0.2mL draws with 0.1mL-graduated syringes introduce ±10% variance. Insulin syringes are required for precision
  • Shelf Life Management
  • 28-day guideline applied universally
  • 28-day maximum with daily visual inspection + potency verification at day 14 via third-party assay if available
  • Peptides with Met/Cys/Trp residues degrade faster than 28-day standard. Mid-cycle verification catches early degradation